Veerauo V Konkankit

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway
    Veerauo V Konkankit
    Graduate Program in Physiological Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, 90095, USA
    J Transl Med 9:192. 2011

Detail Information

Publications1

  1. pmc Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway
    Veerauo V Konkankit
    Graduate Program in Physiological Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, 90095, USA
    J Transl Med 9:192. 2011
    ..However, the absence of well-characterized, highly immunogenic tumor-rejection antigens (TRA) in gliomas has limited the implementation of targeted immune-based therapies...